- Start
- Aug 20, 202690% CONFIDENCEfrom the source
Abbott Settles Gill Case and 2,000 NEC Formula Claims for $670M
- Abbott reached agreements with three law firms to resolve the Gill case and necrotizing enterocolitis (NEC) claims on behalf of approximately 2,000 additional infants for an aggregate of approximately $670 million, rather than continue to appeal or pay approximately $600 million, the Gill judgment plus accrued interest[1]
- A St. Louis jury awarded the Gill plaintiff $495 million in July 2024 after her daughter developed NEC after being fed Similac in the hospital; the Missouri Court of Appeals affirmed the verdict in May 2026[2][4]
- Abbott calls the agreements a compromise of disputed claims and not an admission of liability, and says regulators and medical groups find no reliable scientific evidence that preterm formulas cause NEC[1]
- About 1,700 lawsuits remain in federal and state courts on behalf of approximately 12,700 infants, a count Abbott says includes claims naming both Abbott and Mead Johnson, infants diagnosed before receiving formula and duplicate filings[2]
- The release cites favorable rulings, including the Seventh Circuit's July 2026 affirmance of a pretrial judgment for Abbott in the first federal MDL bellwether and the Illinois Appellate Court's June 2026 reversal of a $60 million verdict against Mead Johnson[1]
- Reuters notes more than 825 federal cases are consolidated before a judge in Chicago, and that NEC, which mostly affects premature newborns, has an estimated mortality rate above 20%[3]
References 486% CONFIDENCE
The first entry is always the pin's source. Overall confidence is a weighted average of how firmly each reference supports the start and end times used above; a reference counts half as much for every 180 days older than the newest.
- [1]90%abbott.mediaroom.com/2026-08-20-Abbott-reaches-agreements-to-resolve-a-portion-of-litigation-involving-its-specialty-formulas-for-preterm-infantsabbott.mediaroom.com· Posted Sep 23, 2026· Starts Aug 20, 2026 ✓· 28% of score
The release is datelined "ABBOTT PARK, Ill., Aug. 20, 2026" and the 8-K says "On August 20, 2026 ... Abbott entered into agreements to resolve the Gill lawsuit".
- [2]90%Abbott Laboratories Form 8-K (August 20, 2026): NEC litigation agreementssec.gov· Published Aug 20, 2026· 24% of score
Abbott's SEC filing (Item 8.01): the ~$670M agreements, the Gill verdict affirmed by the Missouri Court of Appeals in May 2026, and the ~1,700 suits / ~12,700 infants still pending.
- [3]88%Abbott to pay $670 million to settle some preterm infant formula cases (Reuters)wmbdradio.com· Published Aug 20, 2026· 24% of score
Reuters wire story by Dietrich Knauth, carried in full by WMBD: settlement terms, Gill background, 825+ federal cases in Chicago and NEC context.[1]
- [4]75%Abbott to Pay $670M to Settle 2,000 Preterm Infant Formula Lawsuitsharrismartin.com· Published Aug 20, 2026· 24% of score
HarrisMartin MDL trade report: the $670M settlement of 2,000 suits and that Gill's daughter developed NEC after being fed Similac in the hospital.
Suggest a correction
Something missing or wrong? Say it in your own words: a link that backs this pin up, a different start or end date and why, or a fact it lacks or gets wrong. The AI checks it against this pin's sources, searches for better ones, and adds any page that backs you up. The pin's own sources still count most.
